左氧氟沙星与头孢曲松治疗老年细菌性下呼吸道感染临床分析

研究比较左氧氟沙星（ＬＶＬＸ）与头孢曲松（ＣＲＯ）治疗老年细菌性下呼吸道感染的临床疗效和安全性。５６例病人随机分为试验给（ＬＶＬＸ）２７例，２００ｍｇ静脉滴注每日１次，对照组＊ＣＲＯ）２９例，２ｇ静脉滴注，每日１次，疗程均为了０天。评价其临床疗效及安全性，结果，试验组与对照组的临床总有效率和不良反应分别为（８５．１８％）、（７．４％）、（８９．６６％）、（４．１６％），两组差别无显著性（Ｐ〉０．０

An analysis of the therapeutic effect of levofloxacin and ceftriaxone in aged patients with bacterial lower-respiratory infection

To evaluate the curative effect and safety of levofloxacin and ceftriaxone in aged patients with bacterial lower respiratory infection. Fiftysix aged patients with bacterial lower respiratory infection were randomly divided into test group (27 cases) and control group (29 cases). Patients of test group were treated with levofloxacin, 200mg iv drip/d; patients of control group with ceftriaxone, 2g iv drip /d. The overall effective rate and side effect rate of two group were 85.18%, 7.4% and 89.66%, 4.16% respectively, there was no statistical difference between two groups ( P >0.05). Levofloxacin and ceftriaxone have similar curative effect and safety in the treatment of aged patients with bacterial lower respiratory infections.